<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Soares CN</submitter><funding>Bayer AG</funding><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To quantify the burden of sleep disturbances on health-related quality of life (HRQoL) and mental well-being in perimenopausal and postmenopausal women with/without co-occurring vasomotor symptoms (VMS).&lt;h4>Methods&lt;/h4>Perimenopausal and postmenopausal women aged 40 to 65 years who participated in the National Health and Wellness 2019/2021 (US; N=27,621) and 2017/2020 cross-sectional surveys (France, Germany, Italy, Spain, UK; N=20,220) were included. Patient-reported outcomes were HRQoL (Short-Form Health Survey physical and mental component summary scores, EuroQol Visual Analogue Scale, EQ-5D-5L), depression (Patient Health Questionnaire-9), and anxiety (Generalized Anxiety Disorder-7 assessment). Associations between self-reported sleep disturbances and/or VMS and stu</pubmed_abstract><journal>Menopause (New York, N.Y.)</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12915534</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The burden of sleep disturbances on quality of life and mental well-being in nearly 50,000 perimenopausal and postmenopausal women with and without concurrent vasomotor symptoms from the United States and Europe.</pubmed_title><pmcid>PMC12915534</pmcid><pubmed_authors>Modi K</pubmed_authors><pubmed_authors>Maki PM</pubmed_authors><pubmed_authors>Dinkel-Keuthage C</pubmed_authors><pubmed_authors>Drakeley S</pubmed_authors><pubmed_authors>Briggs P</pubmed_authors><pubmed_authors>Genga K</pubmed_authors><pubmed_authors>Moeller C</pubmed_authors><pubmed_authors>Soares CN</pubmed_authors><pubmed_authors>Nguyen J</pubmed_authors><pubmed_authors>Schoof N</pubmed_authors></additional><is_claimable>false</is_claimable><name>The burden of sleep disturbances on quality of life and mental well-being in nearly 50,000 perimenopausal and postmenopausal women with and without concurrent vasomotor symptoms from the United States and Europe.</name><description>&lt;h4>Objectives&lt;/h4>To quantify the burden of sleep disturbances on health-related quality of life (HRQoL) and mental well-being in perimenopausal and postmenopausal women with/without co-occurring vasomotor symptoms (VMS).&lt;h4>Methods&lt;/h4>Perimenopausal and postmenopausal women aged 40 to 65 years who participated in the National Health and Wellness 2019/2021 (US; N=27,621) and 2017/2020 cross-sectional surveys (France, Germany, Italy, Spain, UK; N=20,220) were included. Patient-reported outcomes were HRQoL (Short-Form Health Survey physical and mental component summary scores, EuroQol Visual Analogue Scale, EQ-5D-5L), depression (Patient Health Questionnaire-9), and anxiety (Generalized Anxiety Disorder-7 assessment). Associations between self-reported sleep disturbances and/or VMS and stu</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-07-16T06:35:15.918Z</modification><creation>2026-07-09T10:39:45.372Z</creation></dates><accession>S-EPMC12915534</accession><cross_references><pubmed>41190624</pubmed><doi>10.1097/GME.0000000000002654</doi></cross_references></HashMap>